Covid-19 New

More Info

Open access Aims and Scope Instructions Editorial Guidelines Licensing Copyright

Author's satisfaction with

  • Friendly and hassle-free publication process
  • Less production time of articles
  • Constructive peer-review
  • Enhancing journal reputation
  • Regular feedback system
  • Quick response to authors' queries

Read More

Recently Viewed

Mechanism of Small Molecule Inhibitors of Phagocytosis Advances in Physiological Research: Consideration on Arteria Jaw Subluxation as a Complication of Tardive Dyskinesia Sleep Disorders and Sleep Studies Case Reports Evaluation of Biostimulants Based on Recovered Protein Hydro

Read More

Most Viewed

Evaluation of Biostimulants Based on Recovered Protein Hydro Sinonasal Myxoma Extending into the Orbit in a 4-Year Old: A Feasibility study of magnetic sensing for detecting single-n Physical activity can change the physiological and psycholog Pediatric Dysgerminoma: Unveiling a Rare Ovarian Tumor

Read More

Open Journals

Clinical Images

For Authors Guide For Authors Benefits For Authors Article Processing Charge How To Write a Scientific Paper How To Write a Review Article Short Communication
For Reviewers Benefits For Reviewers How To Review Thanks To Reviewers
For Editors Benefits For Editors Thanks To Editors

Abstract

Review Article

MicroRNA Therapeutics in Triple Negative Breast Cancer

Sarmistha Mitra*

Published: 27 June, 2017 | Volume 1 - Issue 1 | Pages: 009-017

Breast cancer is a complex disease and one of the main causes of cancer-related mortality in women worldwide. In case of approximately 15% of all breast cancers, three markers i.e. estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptors-2 (HER2) are not expressed, and is commonly termed as triple-negative breast cancer (TNBC). Particularly, TNBC is associated with a higher percentage of breast cancer related mortality, which is often aggressive and most frequently found with a BRCA1 mutation or increased basal marker expression. However, due to the limitations of chemotherapy and radiation based treatment; the current challenge is to establish a new strategy of diagnosis and treatment of TNBC. The deregulation of a number of microRNAs (miRNAs) in breast cancer has been widely reported. Therefore, this review is directed towards enhancing our understanding of the involvement of various miRNAs in the pathology of TNBC, their upregulations and downregulations and the effects on various factors. From recent studies a number of miRNAs are found to be related with TNBC, which have great potential to be used as a biomarker to determine the disease prognosis and predict the fate of disease. Again miRNA can be targeted to be applied as a therapeutic to provide a great benefit to the patients of TNBC by finding a new, safe, and effective treatment strategy.

Read Full Article HTML DOI: 10.29328/journal.hjpcr.1001003 Cite this Article Read Full Article PDF

Keywords:

miRNA; HER2; TNBC; Breast cancer

References

  1. Akhtar M, Dasgupta S, Rangwala M. Triple negative breast cancer: an Indian perspective. Breast Cancer (Dove Med Press). 2015; 7: 239-243. Ref.: https://goo.gl/qkjztY
  2. Hudis CA, Gianni L. Triple-negative breast cancer: an unmet medical need. Oncologist. 2011; 16: 1-11. Ref.: https://goo.gl/rCRpbF
  3. Lips EH, Michaut M, Hoogstraat M, Mulder L, Besselink NJ, et al. Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response. Breast Cancer Res. 2015; 17: 134. Ref.: https://goo.gl/5VDvxe
  4. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007; 13: 4429-4434. Ref.: https://goo.gl/ixFkXG
  5. Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network. Cancer. 2012; 118: 5463-5472. Ref.: https://goo.gl/C2W1Un
  6. Sachdev JC, Ahmed S, Mirza MM, Farooq A, Kronish L, et al. Does race affect outcomes in triple negative breast cancer? Breast cancer(Auckl). 2010; 4: 23-33. Ref.: https://goo.gl/DPyd2R
  7. Wei X-Q, Li X, Xin X-J, Tong Z-S, Zhang S. Clinical features and survival analysis of very young (age<35) breast cancer patients. Asian Pacific Journal of Cancer Prevention. 2013; 1: 5949-5952. Ref.: https://goo.gl/MxQDZF
  8. Thomas K, Shiao J, Rao R, Minhajuddin A, Spangler A, et al. Constructing a Clinicopathologic Prognostic Model for Triple-Negative Breast Cancer. American Journal of Hematology/Oncology®, 2017; 13: 11-21. Ref.: https://goo.gl/da2Ue8
  9. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer res. 2005; 65: 7065-7070. Ref.: https://goo.gl/AWPv6j
  10. Schwarzenbacher D, Balic M, Pichler M. The role of microRNAs in breast cancer stem cells. Int J Mol Sci. 2013; 14: 14712-14723. Ref.: https://goo.gl/2ZLHWG
  11. Serpico D, Molino L Di, Cosimo S. microRNAs in breast cancer development and treatment. Cancer Treat Rev. 2014; 40: 595-604. Ref.: https://goo.gl/KNeCPB
  12. Stover DG, Winer EP. Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer. Breast. 2015; 24: 132-135. Ref.: https://goo.gl/RWURDL
  13. Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Modern Pathology. 2011; 24: 157-167. Ref.: https://goo.gl/YYuZYo
  14. Banerjee S, Reis-Filho JS, Ashley S, Steele D, Ashworth A, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol. 2006; 59: 729-735. Ref.: https://goo.gl/ox1RqW
  15. Irvin WJ, Carey LA. What is triple-negative breast cancer? Eur J Cancer. 2008; 44: 2799-2805. Ref.: https://goo.gl/m7Tysk
  16. Rakha EA, El‐Sayed ME, Green AR, Lee AH, Robertson JF, et al. Prognostic markers in triple‐negative breast cancer. Cancer. 2007a; 109: 25-32. Ref.: https://goo.gl/G3oWcS
  17. Rakha EA, Tan DS, Foulkes WD, Ellis IO, Tutt A, at el. Are triple-negative tumours and basal-like breast cancer synonymous? Breast cancer research. 2007b; 9: 404. Ref.: https://goo.gl/VKeMR6
  18. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003; 100: 8418-8423. Ref.: https://goo.gl/XGzMaq
  19. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007; 7: 937-948. Ref.: https://goo.gl/rqLiiJ
  20. Fadare O, Tavassoli FA. Clinical and pathologic aspects of basal-like breast cancers. Nat Clin Pract Oncol. 2008; 5: 149-159. Ref.: https://goo.gl/rbTDYf
  21. Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, et al. How basal are triple‐negative breast cancers? Int J Cancer. 2008; 123: 236-240. Ref.: https://goo.gl/zLpZxL
  22. Calza S, Hall P, Auer G, Bjöhle J, Klaar S, et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 2006; 8: R34. Ref.: https://goo.gl/zAJs3q
  23. Hashmi AA, Edhi MM, Naqvi H, Faridi N, Khurshid A, et al. Clinicopathologic features of triple negative breast cancers: an experience from Pakistan. Diagn Pathol. 2014; 9: 43. Ref.: https://goo.gl/CbeVRJ
  24. Cheng H, Qin Y, Fan H, Su P, Zhang X, et al. Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagn Pathol. 2013; 8: 129. Ref.: https://goo.gl/YcLpjk
  25. Klingen TA, Chen Y, Suhrke P, Stefansson IM, Gundersen MD, et al. Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas. Diagn Pathol. 2013; 8: 80. Ref.: https://goo.gl/BCFoZv
  26. Liu L, Liu Z, Qu S, Zheng Z, Liu, et al. Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients. Diagn Pathol. 2013b; 8: 71. Ref.: https://goo.gl/Zs3pTt
  27. Nass N, Dittmer A, Hellwig V, Lange T, Beyer JM, et al. Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response. Oncotarget. 2016; 7: 38408-38426. Ref.: https://goo.gl/QVgCfH
  28. Yamagishi Si, Matsui T, Fukami K. Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk. Rejuvenation Res. 2015; 18: 48-56. Ref.: https://goo.gl/UkVvuy
  29. Radia A-M, Yaser A-M, Ma X, Zhang J, Yang C, et al. Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines. Int J Mol Sci. 2013; 14: 7959-7978. Ref.: https://goo.gl/CmgGy4
  30. Svoboda M, Sana J, Redova M, Navratil J, Palacova M, et al. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagn Pathol. 2012; 7: 31. Ref.: https://goo.gl/YZJ4Rb
  31. Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, et al. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol. 2012; 7: 27. Ref.: https://goo.gl/Cv32X7
  32. Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006; 19: 264-271. Ref.: https://goo.gl/x6U4g8
  33. Fulford L, Easton D, Reis‐Filho J, Sofronis A, Gillett C, et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology. 2006; 49: 22-34. Ref.: https://goo.gl/wNDjAk
  34. Reis‐Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, et al. Metaplastic breast carcinomas are basal‐like tumours. Histopathology. 2006; 49: 10-21. Ref.: https://goo.gl/7yuofu
  35. Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007; 8: 235-244. Ref.: https://goo.gl/bTe5m9
  36. Carter M, Hornick JL, Lester S, Fletcher CD. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 2006; 30: 300-309. Ref.: https://goo.gl/UYu7xG
  37. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer. 1990a; 65: 272-276. Ref.: https://goo.gl/ZhMcrA
  38. Rosen PP, Ernsberger D. Low-Grade Adenosquamous Carcinoma: A Variant of Metaplastic Mammary Carcinoma. Am J Surg Pathol. 1987; 11: 351-358. Ref.: https://goo.gl/jbrMzF
  39. Hanna W, Kahn HJ. Ultrastructural and immunohistochemical characteristics of mucoepidermoid carcinoma of the breast. Hum Pathol. 1985; 16: 941-946. Ref.: https://goo.gl/z1AY4D
  40. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol. 1990b; 21: 1142-1150. Ref.: https://goo.gl/2PU5oL
  41. Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, et al. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol. 2001; 25: 1009-1016. Ref.: https://goo.gl/JVCMpx
  42. Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn. 2010; 10: 297-308. Ref.: https://goo.gl/21xJAU
  43. Le X-F, Merchant O, Bast RC, Calin, GA. The roles of microRNAs in the cancer invasion-metastasis cascade. Cancer Microenviron. 2010; 3:137-147. Ref.: https://goo.gl/S73wzr
  44. Negrini M, Calin GA. Breast cancer metastasis: a microRNA story. Breast Cancer Res. 2008; 10: 203. Ref.: https://goo.gl/H727oi
  45. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007; 8: 214.Ref.: https://goo.gl/J2kvV8
  46. Van Schooneveld E,Wildiers H, Vergote I, Vermeulen PB, Dirix LY, et al. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res. 2015; 17: 21. Ref.: https://goo.gl/eRZ3Dz
  47. Lehmann BD, Bauer JA, Chen X. Sanders ME, Chakravarthy AB, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011; 121: 2750-2767. Ref.: https://goo.gl/JdPQuW
  48. Kurozumi S, Yamaguchi Y, Kurosumi M, Ohira M, Matsumoto H, et al. Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes. J Hum Genet. 2017; 62: 15-24. Ref.: https://goo.gl/2beH8d
  49. Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, et al. Down‐regulation of BRCA1 expression by miR‐146a and miR‐146b‐5p in triple negative sporadic breast cancers. EMBO Mol Med. 2011b; 3: 279-290. Ref.: https://goo.gl/uyDCs7
  50. Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E. Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med. 2011a; 3: 279-290. Ref.: https://goo.gl/b6LLyy
  51. Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, et al. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 2008; 29: 1963-1966. Ref.: https://goo.gl/vsxoFy
  52. Crippa E, Lusa L, De Cecco L, Marchesi E, Calin GA, et al. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer. PloS one. 2014; 9. Ref.: https://goo.gl/hGwK4D
  53. Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell. 2011; 41: 210-220. Ref.: https://goo.gl/hcRb6n
  54. Tanic M, Yanowski K, Gómez‐López G, Rodriguez‐Pinilla MS, Marquez‐Rodas I, et al. MicroRNA expression signatures for the prediction of BRCA1/2 mutation‐associated hereditary breast cancer in paraffin‐embedded formalin‐fixed breast tumors. Int J Cancer. 2015; 136: 593-602. Ref.: https://goo.gl/grGd5T
  55. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007; 316: 608-611. Ref.: https://goo.gl/GF482e
  56. Zonari E, Pucci F, Saini M, Mazzieri R, Politi LS, et al. A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective anti-tumor responses. Blood. 2013. Ref.: https://goo.gl/hGCSBT
  57. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10: 593-601. Ref.: https://goo.gl/zVDmYo
  58. Gebeshuber CA, Zatloukal K, Martinez J. miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009; 10: 400-405. Ref.: https://goo.gl/441YmF
  59. Jiang H, Zhang G, Wu JH, Jiang CP. Diverse roles of miR-29 in cancer (review). Oncol Rep. 2014; 31: 1509-1516. Ref.: https://goo.gl/fnLsKJ
  60. Gaur AB, Holbeck SL, Colburn NH, Israel MA. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol. 2011; 13: 580-590. Ref.: https://goo.gl/byJacU
  61. Wang Q, Liu S, Tang Y, Liu Q, Yao Y. MPT64 protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway. PloS one. 2014; 9. Ref.: https://goo.gl/aJ5xsF
  62. Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, et al. Gap junction-mediated import of MicroRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res. 2011; 71: 1550-1560. Ref.: https://goo.gl/pvkf4M
  63. Eichelser C, Stuckrath I, Muller V, Milde-Langosch K, Wikman H, et al. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget. 2014; 5: 9650-9663. Ref.: https://goo.gl/hTpniA
  64. Chen J, Shin VY, Siu MT, Ho JC, Cheuk I, et al. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. BMC cancer. 2016; 16: 887. Ref.: https://goo.gl/JRTnbS
  65. Abdellatif M. Differential expression of microRNAs in different disease states. Circ Res. 2012; 110: 638-650. Ref.: https://goo.gl/8DbLUY
  66. Kaboli PJ, Rahmat A, Ismail P, Ling KH. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacol Res. 2015; 97: 104-121. Ref.: https://goo.gl/2KEucF
  67. Kim NH, Kim HS, Li XY, Lee I, Choi HS, et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol. 2011; 195: 417-433. Ref.: https://goo.gl/16dmCU
  68. Song SJ, Poliseno L, Song MS, Ala U, Webster K, et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell. 2013; 154: 311-324. Ref.: https://goo.gl/mFpe5j
  69. Graveel CR, Calderone HM, Westerhuis JJ, Winn ME, Sempere LF. Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast Cancer (Dove Med Press). 2015; 7: 59-79. Ref.: https://goo.gl/MeC4Ze
  70. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449: 682-688. Ref.: https://goo.gl/T28Wx1
  71. Li X, Pan YZ, Seigel GM, Hu ZH, Huang M, et al. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328,-519c and-520h) and their differential expression in stem-like ABCG2+ cancer cells. Biochem Pharmacol. 2011; 81: 783-792. Ref.: https://goo.gl/AJpbNX
  72. Amschler K, Schön MP, Pletz N, Wallbrecht K, Erpenbeck L, et al. NF-κB inhibition through proteasome inhibition or ikkβ blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways. Journal of Investigative Dermatology. 2010; 130: 1073-1086. Ref.: https://goo.gl/4LZLsx
  73. Eichelser C, Stückrath I, Müller V, Milde-Langosch K, Wikman H, et al. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget. 2014b; 5: 9650-9663. Ref.: https://goo.gl/rHgdDT
  74. Gabriely G, Teplyuk NM, Krichevsky AM. Context effect: microRNA-10b in cancer cell proliferation, spread and death. Autophagy. 2011; 7: 1384-1386. Ref.: https://goo.gl/JeGrjH
  75. Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, et al. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res. 2009; 315: 2529-2538. Ref.: https://goo.gl/pQ5E1y
  76. Okoye JO, Okoye FO. miRNA and Target Oncogene Regulation in Triple Negative Breast Cancer: An Age, Ethnic and Environmental Related Neoplastic Event. JCTI. 2015; 2: 66-80. Ref.: https://goo.gl/LAue9x
  77. Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos DA, et al. MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell cycle. 2011; 10: 507-517. Ref.: https://goo.gl/epHQG9
  78. Wang Y, Rathinam R, Walch A, Alahari SK. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem. 2009; 284: 23094-23106. Ref.: https://goo.gl/d2hUNM
  79. Wu Q, Wang C, Lu Z, Guo L, Ge Q. Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim acta. 2012; 413: 1058-1065. Ref.: https://goo.gl/rZXH2c
  80. Zavala V, Pérez-Moreno E, Tapia T, Camus M, Carvallo P. MiR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival. Cancer Biomarkers. 2016; 16: 99-107. Ref.: https://goo.gl/Tm2PTf
  81. Liu H, Wang Y, Li X, Zhang Y-j, Li J, et al. Expression and regulatory function of miRNA182 in triple-negative breast cancer cells through its targeting of profilin 1. Tumour Biol. 2013a; 34: 1713-1722. Ref.: https://goo.gl/hVysfE
  82. Mattiske S, Suetani RJ, Neilsen PM, Callen DF. The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol Biomarkers Prev. 2012; 21: 1236-1243. Ref.: https://goo.gl/5FGVmG
  83. Ding L, Ni J, Yang F, Huang L, Deng H, et al. Promising therapeutic role of miR-27b in tumor. Tumour Biol. 2017; 39. Ref.: https://goo.gl/DhSVYM
  84. Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, et al. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer. Cancer Res. 2013; 73: 2884-2896. Ref.: https://goo.gl/JHqgXT
  85. Fkih M'hamed I, Privat M, Ponelle F, Penault-Llorca F, Kenani A. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. Cell Oncol (Dordr). 2015; 38: 433-442.Ref.: https://goo.gl/HxFqof
  86. Fkih M'hamed I, Privat M, Trimeche M, Penault-Llorca F, Bignon YJ. et al. miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers. Pathol Oncol Res. 2017. Ref.: https://goo.gl/7y1JFS

Similar Articles

  • MicroRNA Therapeutics in Triple Negative Breast Cancer
    Sarmistha Mitra* Sarmistha Mitra*. MicroRNA Therapeutics in Triple Negative Breast Cancer . . 2017 doi: 10.29328/journal.hjpcr.1001003; 1: 009-017
  • Rosai-Dorfman disease presenting as a breast mass
    Ding Dai*, Qi Cai, Nasreen A. Vohra, Jan Wong, Zsuzsanna P. Therien, Karlene Hewan-Lowe and Ann Sutton Ding Dai*,Qi Cai, Nasreen A. Vohra,Jan Wong, Zsuzsanna P. Therien,Karlene Hewan-Lowe,Ann Sutton. Rosai-Dorfman disease presenting as a breast mass . . 2019 doi: 10.29328/journal.apcr.1001012; 3: 008-014

Recently Viewed

Read More

Most Viewed

Read More

Contact

Editorial Office Emails:

info@hspioa.org

amelia.sandra@hspioa.us

elena.maya@hspioa.us

Select by Volume & Issue

Submit Manuscript Information for Authors Advisory Board Rss Feed Articles Rss Feed

Most Viewed Keywords

University/Institution

Select and search by University/Institution.

Articles by Country

Select and search by country to get related articles.

Testmonials

I would like to thank JPRA for taking this decision. I understand the effort it represents for you. I'm truly happy to have the paper published in JPRA. And I'll certainly consider JPRA for my next publications as I was satisfied of the service provided, the efficiency and promptness of the interactions we had.

Emmanuel BUSATO

Publishing with the International Journal of Clinical and Experimental Ophthalmology was a rewarding experience as review process was thorough and brisk. Their visibility online is second to none as their published articles appear in all search engines. I will encourage researchers to publish with them.

Elizabeth Awoyesuku

“The choice to submit the forensic case study to the Journal of Addiction Therapy and Research was dictated by the match between the content and the potential readership. The publication process proved to be expedient and we were provided with constructive feedback from reviewers. The final article layout is attractive and conforms to standards. All-in-all, it has been a rewarding process.”

Elisabeth H Wiig

Archives of Vascular Medicine is one of the top class journal for vascular medicine with highly interesting topics. You did a professional and great Job!

Elias Noory

Thank you very much. I think the review process and all of what concerns the administration of the publication concerning our paper has been excellent. The nice and quick answers have been very good I think.

Doris Nilsson

Journal of Pulmonary and Respiratory Research is good journal for respiratory research purposes. It takes 2-3 weeks maximum for review of the manuscript to get published and any corrections to be made in the manuscript. It needs good articles and studies to get publish in the respiratory medicine. I am really glad that this journal editors helped me to get my case report published.

Divya Khanduja

Thanks you and your colleague for the great help for our publication. You always provide prompt responses and high quality of service. I am so happy to have you working with me. Thanks again!

Diana (Ding) Dai

Service and process were excellent as was the “look” of the article when published.

Deane Waldman

Great, thank you! It was very efficient working w/ your group. Very thorough reviews (i.e., plagiarism, peer, etc.). Would certainly recommend that future authors consider working w/ your group.

David W Brett

Your services are very good

Chukwuka Ireju Onyinye

I very much appreciate the humanitarian services provided in my stead by this journal/publisher. It exhibits total absence of editorial impertinence. As an Author, I have been guided to have a fruitful experience. The editorial care is highly commendable.

Chrysanthus Chukwuma

"An amazing experience with the Journal of Advanced Pediatrics and Child Health. Very fast blind review with pertinent corrections and suggestions. I highly recommand both the journal and the editor."

Chaimae Khairoun

The submission is very easy and the time from submission to response from the reviewers is short. Correspondence with the journal is nice and rapid.

Catrin Henriksson

The Clinical Journal of Obstetrics and Gynecology is an open access journal focused on scientific knowledge publication with emphasis laid on the fields of Gynecology and Obstetrics. Their services toward us have been encouraging through their kindness and respect. Great consideration has been given to us as young budding researchers and we are very grateful for this.

Carole Assontsa

During the process your positive communication, prompt feedback and professional approach is very highly appreciated. We would like to thank you very much for your support.

Can Vuran

I do appreciate for your service including submission, analysis, review, editorial and publishing process. I believe these esteemed journal enlighten the science with its high-quality personel.

Bora Uysal

I am very much pleased with the fast track publication by your reputed journal's editorial team. It is really helpful for researchers like me from developing nations. I strongly recommend your journal for publication.

Badri Kumar Gupta

It has been a fabulous journey writing articles for your journal because of the encouragement you people provide for writers from developing nations like India. Kindly continue the same. Looking forward for a long term association.

Badareesh Lakshminarayana

Many thanks for publishing my article in your great journal and the friendly and hassle-free publication process, the constructive peer-review, the regular feedback system, and the Quick response to any queries.

Azab Elsayed Azab

I would like to thank this journal for publishing my Research Article. Something I really appreciate about this journal is, they did not take much time from the day of Submission to the publishing date. Looking forward to have more publications in future.

Ayush Chandra

Submission of paper was smooth, the review process was fast. I had excellent communication and on time response from the editor.

Ayokunle Dada

Your service is very good and fast reply, also your service understand our situation and support us to publication our articles.

Ayman M Abu Mustafa

Really good service with prompt response. Looking forward to having long lasting relationship with your journal

Avishek Bagchi

Your service is excellent. Processing and editing were very fast. I hope to publish more of my works in your journal.

Ausraful Islam

I wanna to thank Clinical Journal of Nursing Care and Practice for its effort to review and publish my manuscript. This is reputable journal. Thank you!

Atsedemariam Andualem

“It was a delightful experience publishing my manuscript with the Clinical Journal of Obstetrics and Gynecology. They offered me lots of opportunities I never had from most publishing houses and their prompt services are greatly appreciated.”

Asafo Jones

I hope to ability to make some new investigation and publish in Your Company in future.

Artur Stopyra

I like the quality of the print & overall service. The paper looks quite impressive. Hope this will attract interested readers. All of you have our best wishes for continued success.

Arshad Khan

Your big support from researchers around the world is the best appreciation from your scientific teams. We believe that there should be no barrier in science and you make it real and this motto come true.

Arefhosseinir Rafi

Your journal co-operation is very appreciable and motivational. I am really thankful to your journal and team members for the motivation and collaboration to publish my work.

Assistant Professor, UCLAS Uttaranchal University, Dehradun, India

Archna Dhasmana

I am glad to submit the article to Heighten Science Publications as it has a very smooth and fast peer-review process, which enables the researchers to communicate their work on time.

Anupam M

This is to specify that I have had an extensive and detailed interaction with the Editorial team of Annals of Clinical Gastroenterology and Hepatology, USA, lasting over a significant period of time. My interaction has been extremely pleasant, especially with Ms Allie Smith, as I find the communication quite inspiring and crystal clear. The attitude of aforesaid individuals is quite helpful and guiding in pertinent instances. It has been a commemorative journey so far working with the Journal and I hope that the symbiosis will continue, evolve and flourish in the forthcoming years. I wish the journal, related personnel and aforementioned individuals a fruitful, successful run.

New Delhi, India

Anubha Bajaj

We appreciate the fact that you decided to give us full waiver for the applicable charges and approve the final version. You did an excellent job preparing the PDF version. Of course we will consider your magazine for our future submissions and we will pay the applicable fees then.

Anna Dionysopoulou

''Co-operation of Archives of Surgery and Clinical Research journal is appreciable. I'm impressed at the promptness of the publishing staff and the professionalism displayed. Thank you very much for your support, help and encouragement.''

Anıl Gokce

Congratulations for the excellence of your journal and high quality of its publications.

Angel MARTIN CASTELLANOS

The service from the journal staff has been excellent.

Andy Smith

I was very pleased with the quick editorial process. We are sure that our paper will have great visibility, among other things due to its open access. We believe in science accessible to all.

Anderson Fernando de Souza

It was a great experience publishing through JCICM. The article has reached out to several institutions. Appreciate your professional work. Hope to work with you again

Anas Wardeh

Publishing an article is a long process, but working with your publication department made things go smoothly, even though the process took exactly 5 months from the time of submitting the article till the time I have favourable response, the missing part is the peer review details, which is essential in self auditing and future improvement, overall experience was excellent giving your understanding of the situation of lack of financial institution support.

Anas Diab

I think that Heighpubs very good. You are very helpful. Thank you for everything.

Ana Ribeiro

Regarding to be services, we note that are work with high standards of professionalism translated into quick response, efficiency which makes communication accessible. Furthermore, I believe to be much inviting for the submission of future works for publication purposes.

Amélia João Alice Nkutxi

I would like to mention that I had a wonderful experience working with HSPI. The whole process right from manuscript submission to peer review till the publication of the article was very prompt & efficient. I wish you good luck for the future.

Amarjeet Gambhir

Once I submitted the manuscript, the response time of the reviewers was very fast. The fine-tuning of the galley proof was likewise prompt. I believe the journal provide a valuable outlet to disseminate physical rehabilitation scientific knowledge to the clinical community. Respectfully. Dr. Alon

Alon

We really appreciate and thanks the full waiver you provide for our article. We happy to publish our paper in your journal. Thank you very much for your good support and services.

Ali Abusafia

It was a real pleasure working with your team. The review was done fast, and it was very clear, the editing was flawless, the article was published quickly compared to other journals, and everyone was understanding and helpful. I will gladly recommend this journal to my acquaintances in academia.

Alexandra Cozma

To the editorial team at HSPI and the Journal of Clinical Nephrology: Thank you so much for your hard work and collaboration in bringing our article to life. Your staff was responsive, flexible, and communicative and made the process smooth and easy. Thank you!

Alejandro Munoz

Dear colleagues! I am satisfied with our cooperation with you. Your service is at a high level. I hope for a future relationship. Let me know if I can get a paper version of the magazine with my articles from you. I see them on the Internet.

Aksenov V.V

"This is my first time publishing with the journal/publisher. I am impressed at the promptness of the publishing staff and the professionalism displayed. Thank you for encouraging young researchers like me!"

Ajite Kayode

I want to thank you for our collaboration. You were fast and effective with a positive spirit of teamwork. I am truly excited from our collaboration. You were like always fast, efficient and accurate. I hope that in the near future we will collaborate again.

Aikaterini Solomou

In my opinion, you provide a very fast and practical service.

Ahmet Eroglu

Great, We are too comfortable with the process including the peer review process and quality. But, the journal should be indexed in different databases such scopus.

Afework Edmealem

We really appreciate your efforts towards our article, the professional way you handle our request for exemption from charges. It was a great honor for us to publish in your magazine.

Achraf elbakkaly

I really liked the ease of submitting my manuscript in the HSPI journal. Further, the peer review was timely completed and I was communicated the final decision on my manuscript within 10 days of submission which is really appreciable. I strongly recommend all the scientists and researchers to submit their work in this journal”

Abu Bashar

My candid opinion is that the service you render is second to none. My favourite part is the prompt response to issue, really i value that.

Abiodun Akanbi Adeogun

Thank you very much for accepting our manuscript in your journal “International Journal of Clinical Virology”. We are very thankful to the esteemed team for timely response and quick review process. The editorial team of International Journal of Clinical Virology is too cooperative and well-mannered during the publication process. We are hopeful to publish many quality papers in your journal and I suggest the International Journal of Clinical Virology to all of my colleagues, researchers and friends to publish their research here.

Abdul Baset

I, Muhammad Sarwar Khan, am serving as Editor on Archives of Biotechnology and Biomedicine (ABB). I submitted an editorial titled, 'Edible vaccines to combat Infectious Bursal Disease of poultry' for publication in ABB. After submitting the manuscript; the services rendered by the management and technical personnel to handle and process the manuscript were marvelous. Plagiarism report was shared with me with complements before reviewers' comments, All steps including article processing and service charges were well taken care of keeping in view the author's interest/preference. All together, it was an encouraging and wonderful experience working with ABB personnel.

University of Agriculture, Pakistan

Muhammad Sarwar Khan

Your journal has accomplished its intended mission of providing very effective and efficient goals in dealing with submissions, conducting the reviewing process and in publishing accepted manuscripts in a timely manner. Keep up the great work and services that you provide.

University of Jacqmar, Inc., USA

John St. Cyr

I am to express my view that Heighten Science Publications are reliable quick even after peer review process. I hope and wish the publications will go a long way in disseminating science to many interested in scientific research.

College of Fisheries, CAU(I), Tripura, India

Ajit Kumar Roy

The Journal Clinical Nephrology provides a good opportunity for readers to stay updated in the field of clinical nephrology. Additionally - it provides a good opportunity for authors to publish their work. 1. Publication of the accepted manuscripts is sufficiently rapid. 2. The trust factor between the journal and me, as an author, is very important and well preserved. 3. Peer review process very rapid and effective.

Assaf Harofeh Medical Center, Israel

Leonid Feldman

In 2017, I submitted a manuscript to the journal Archives of Biotechnology and Biomedicine belonging to Heighten Science Publications Corporation. Within one week I already received the response from the editor. All processing steps were really fast so in terms of a speedy publication I can particularly recommend the journal Archives of Biotechnology and Biomedicine. The responsible contact person of the journal was always available, which gives a trustworthy impression to the author. Also the peer review process was clear and constructive. So from my experience with Heighten Science Publications Corporation I can recommend publishing there.

University of Tubingen, Germany

Yvonne Mast

We thank to the heighten science family, who speed up the publication of our article and provide every support.

Mehmet Besir

The services of the journal were excellent. The most important thing for an author is the speed of the peer review which was really fast here. They returned in a few days and immediately replied all of my questions. I want to refer this platform to all scholars. Many thanks.

Eastern Mediterranean University, Cyprus

Zehra Guchan TOPCU

Thank you for your attitude and support. I am sincerely grateful to you and the entire staff of the magazine for the high professionalism and fast quality work. Thank you very much!

USA

Igor Klepikov

Thank you and your company for effective support of authors which are very much dependable on the funds gambling for science in the different countries of our huge and unpredictable world. We are doing our work and should rely on a teams like Galley Proof-HSPC. Great success to all of you for the 2019th! Be well all the year long.

Russia

Victor V Apollonov

The editorial process was quickly done. The galley proof was sent within a week after being accepted for publication. The editorial team was very helpful and responded promptly.

India

Rohit Kulshrestha

Publishing with the International Journal of Clinical and Experimental Ophthalmology was a rewarding experience as review process was thorough and brisk. Their visibility online is second to none as their published articles appear in all search engines. I will encourage researchers to publish with them.

University of Port Harcourt Teaching Hospital, Nigeria

Dr. Elizabeth A Awoyesuku

"It was a pleasure to work with the editorial team of the journal on the submission of the manuscript. The team was professional, fast, and to the point".

NC A&T State University, USA

Moran Sciamama-Saghiv

Submission of paper was smooth, the review process was fast. I had excellent communication and on time response from the editor.

Ekiti State University Teaching Hospital, Nigeria

Ayokunle Dada

I am delighted and satisfied with. Heighten Science Publications as my manuscript was thoroughly assessed and published on time without delay. Keep up the good work.

Ido-Ekiti/Afe Babalola University, Nigeria

Dr. Shuaib Kayode Aremu

"This is my first time publishing with the journal/publisher. I am impressed at the promptness of the publishing staff and the professionalism displayed. Thank you for encouraging young researchers like me!"

Ekiti State University, Nigeria

Adebukola Ajite

I wanna to thank clinical journal of nursing care and practice for its effort to review and publish my manuscript. This is reputable journal. Thank you!

Wollo University, Ethiopia

Atsedemariam Andualem

We appreciate your approach to scholars and will encourage you to collaborate with your organization, which includes interesting and different medical journals. With the best wishes of success, creativity and joy in life, prosperity in the medical field.

Ivano- Frankivsk National Medical University, Ukraine

Nataliya Kitsera

Thank you very much for your support and encouragement. I am truly impressed by your tolerance and support. Thank you very much

Diaverum: PADC, Jeddah, Saudi Arabia

Nasrulla Abutaleb

You are such a nice person. Your journal co-operation is very appreciable and motivational.

Department of Biotechnology, Uttaranchal college of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India

Archna Dhasmana

“Mobile apps and wearable technology are becoming ubiquitous in our environment. Their integration with healthcare delivery is just beginning to take shape. The early results are promising and the possibilities great."

BS, PharmD., MBA, CPHIMS, FHIMSS, Adjunct Professor, Global Healthcare Management, MCPHS University, Chief Strategy Offi cer, MedicaSoft, Senior Advisor, National Health IT (NHIT) Collaborative for Underserved, New York HIMSS, National Liaison, Health 2.0 Boston, Past Chair, Chair Innovation, USA

Helen Figge

“The choice to submit the forensic case study to the Journal of Addiction Therapy and Research was dictated by the match between the content and the potential readership. The publication process proved to be expedient and we were provided with constructive feedback from reviewers. The final article layout is attractive and conforms to standards. All-in-all, it has been a rewarding process.”

Ph.D, Boston University Department of Communication Sciences and Disorders and Knowledge Research Institute, Inc., 2131 Reflection Bay Drive, Arlington, Texas 76013, USA

Elisabeth H. Wiig

The service is nice and the time of processing the application is fast.

Department of Neurosurgery, Queen Elizabeth Hospital, Hong Kong

Long Ching

Your service is very good and fast reply, Also your service understand our situation and support us to publication our articles.

Palestine College of Nursing, Khan Younis, Gaza Strip, Palestine

Ayman M Abu Mustafa

“It was a delightful experience publishing my manuscript with the Clinical Journal of Obstetrics and Gynecology. They offered me lots of opportunities I never had from most publishing houses and their prompt services are greatly appreciated.”

Department of Agricultural Economics, Agribusiness and Extension, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Akowuah Jones Asafo

View More

Related Journals

Help ?